Larry A. Harshyne

7.3k total citations
58 papers, 1.5k citations indexed

About

Larry A. Harshyne is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Larry A. Harshyne has authored 58 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 20 papers in Immunology and 13 papers in Molecular Biology. Recurrent topics in Larry A. Harshyne's work include Cancer Immunotherapy and Biomarkers (27 papers), Immunotherapy and Immune Responses (11 papers) and Head and Neck Cancer Studies (10 papers). Larry A. Harshyne is often cited by papers focused on Cancer Immunotherapy and Biomarkers (27 papers), Immunotherapy and Immune Responses (11 papers) and Head and Neck Cancer Studies (10 papers). Larry A. Harshyne collaborates with scholars based in United States, Greece and Australia. Larry A. Harshyne's co-authors include Simon M. Barratt‐Boyes, Simon C. Watkins, Andrea Gambotto, Michael I. Zimmer, D. Craig Hooper, David W. Andrews, Lawrence C. Kenyon, Adam Luginbuhl, Joseph Curry and Jennifer M. Johnson and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Larry A. Harshyne

56 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Larry A. Harshyne United States 18 855 554 489 214 132 58 1.5k
Jürgen Krauß Germany 19 239 0.3× 391 0.7× 304 0.6× 78 0.4× 157 1.2× 61 1.1k
Anita Tandle United States 21 146 0.2× 766 1.4× 320 0.7× 324 1.5× 122 0.9× 33 1.2k
Mattias K. Andersson Sweden 23 148 0.2× 568 1.0× 390 0.8× 133 0.6× 103 0.8× 44 1.4k
Silvio Roncella Italy 24 651 0.8× 524 0.9× 621 1.3× 128 0.6× 169 1.3× 87 1.9k
Yoshinori Suminami Japan 19 339 0.4× 521 0.9× 337 0.7× 332 1.6× 78 0.6× 41 1.2k
David C. Weksberg United States 12 698 0.8× 491 0.9× 260 0.5× 119 0.6× 157 1.2× 18 1.6k
Susan E. Lyons United States 21 349 0.4× 360 0.6× 99 0.2× 102 0.5× 428 3.2× 31 1.9k
Sébastien Albert France 19 302 0.4× 317 0.6× 387 0.8× 63 0.3× 73 0.6× 39 1.0k
Hélène Salmon France 12 974 1.1× 479 0.9× 1.1k 2.2× 256 1.2× 231 1.8× 20 1.8k
Daoud Sie Netherlands 26 374 0.4× 1.6k 2.8× 451 0.9× 1.2k 5.6× 204 1.5× 55 2.6k

Countries citing papers authored by Larry A. Harshyne

Since Specialization
Citations

This map shows the geographic impact of Larry A. Harshyne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry A. Harshyne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry A. Harshyne more than expected).

Fields of papers citing papers by Larry A. Harshyne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larry A. Harshyne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry A. Harshyne. The network helps show where Larry A. Harshyne may publish in the future.

Co-authorship network of co-authors of Larry A. Harshyne

This figure shows the co-authorship network connecting the top 25 collaborators of Larry A. Harshyne. A scholar is included among the top collaborators of Larry A. Harshyne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larry A. Harshyne. Larry A. Harshyne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Linnenbach, Alban J., Andrew P. South, Ubaldo Martinez‐Outschoorn, et al.. (2025). Tumor microenvironment governs the prognostic landscape of immunotherapy for head and neck squamous cell carcinoma: A computational model-guided analysis. PLoS Computational Biology. 21(6). e1013127–e1013127. 1 indexed citations
2.
Johnson, Jennifer M., Ioannis Vathiotis, Larry A. Harshyne, et al.. (2023). Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck. Journal for ImmunoTherapy of Cancer. 11(8). e007141–e007141. 9 indexed citations
3.
4.
Harshyne, Larry A., et al.. (2022). 689P Effects of durvalumab-metformin on head and neck squamous cell carcinoma (HNSCC) as revealed by digital spatial profiling (DSP). Annals of Oncology. 33. S858–S858. 1 indexed citations
5.
6.
Harshyne, Larry A., et al.. (2021). Cytokine Profiling in Low- and High-Density Small Extracellular Vesicles from Epidermoid Carcinoma Cells. SHILAP Revista de lepidopterología. 1(4). 100053–100053. 8 indexed citations
7.
South, Andrew P., Ulrich Rodeck, Ubaldo Martinez‐Outschoorn, et al.. (2020). Cancer-Associated Fibroblast Density, Prognostic Characteristics, and Recurrence in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis. Frontiers in Oncology. 10. 565306–565306. 58 indexed citations
8.
Zinner, Ralph, Jennifer M. Johnson, Madalina Tuluc, et al.. (2020). 968P Neoadjuvant nivolumab (N) plus weekly carboplatin (C) and paclitaxel (P) outcomes in HPV(-) resectable locally advanced head and neck cancer. Annals of Oncology. 31. S682–S682. 10 indexed citations
9.
Swendseid, Brian, Larry A. Harshyne, Nancy J. Philp, et al.. (2019). Prognostic Significance of Tumor-Associated Macrophage Content in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis. Frontiers in Oncology. 9. 656–656. 98 indexed citations
10.
Topf, Michael C., Madalina Tuluc, Larry A. Harshyne, & Adam Luginbuhl. (2017). Macrophage type 2 differentiation in a patient with laryngeal squamous cell carcinoma and metastatic prostate adenocarcinoma to the cervical lymph nodes. Journal for ImmunoTherapy of Cancer. 5(1). 60–60. 10 indexed citations
11.
Alexander, Gregory S., Joshua D. Palmer, Madalina Tuluc, et al.. (2016). Immune biomarkers of treatment failure for a patient on a phase I clinical trial of pembrolizumab plus radiotherapy. Journal of Hematology & Oncology. 9(1). 96–96. 21 indexed citations
12.
Cárdenas, Ana María, Erin H. Graf, Larry A. Harshyne, et al.. (2016). Human parechovirus and enterovirus initiate distinct CNS innate immune responses: Pathogenic and diagnostic implications. Journal of Clinical Virology. 86. 39–45. 11 indexed citations
13.
Harshyne, Larry A., et al.. (2015). Serum exosomes and cytokines promote a T-helper cell type 2 environment in the peripheral blood of glioblastoma patients. Neuro-Oncology. 18(2). 206–215. 75 indexed citations
14.
Morin‐Brureau, Mélanie, et al.. (2015). Enhancement of glioma-specific immunity in mice by “NOBEL”, an insulin-like growth factor 1 receptor antisense oligodeoxynucleotide. Cancer Immunology Immunotherapy. 64(4). 447–457. 11 indexed citations
15.
Harshyne, Larry A., David W. Andrews, Lawrence C. Kenyon, et al.. (2013). Glioma Grade Is Associated with the Accumulation and Activity of Cells Bearing M2 Monocyte Markers. Clinical Cancer Research. 19(14). 3776–3786. 156 indexed citations
16.
Harshyne, Larry A., Michael I. Zimmer, Simon C. Watkins, & Simon M. Barratt‐Boyes. (2003). A Role for Class A Scavenger Receptor in Dendritic Cell Nibbling from Live Cells. The Journal of Immunology. 170(5). 2302–2309. 142 indexed citations
17.
Harshyne, Larry A., et al.. (2003). Novel Training Concepts and Techniques Used to Increase Safety Awareness in the Laboratory Animal Facility. Lab Animal. 32(6). 38–42. 1 indexed citations
18.
Barratt‐Boyes, Simon M., Michael I. Zimmer, & Larry A. Harshyne. (2002). Changes in dendritic cell migration and activation during SIV infection suggest a role in initial viral spread and eventual immunosuppression. Journal of Medical Primatology. 31(4-5). 186–193. 14 indexed citations
19.
Harshyne, Larry A., Simon C. Watkins, Andrea Gambotto, & Simon M. Barratt‐Boyes. (2001). Dendritic Cells Acquire Antigens from Live Cells for Cross-Presentation to CTL. The Journal of Immunology. 166(6). 3717–3723. 244 indexed citations
20.
Barratt‐Boyes, Simon M., Michael I. Zimmer, Larry A. Harshyne, et al.. (2000). Maturation and Trafficking of Monocyte-Derived Dendritic Cells in Monkeys: Implications for Dendritic Cell-Based Vaccines. The Journal of Immunology. 164(5). 2487–2495. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jürgen Krauß Breakdown of academic impact, for papers by Anita Tandle Breakdown of academic impact, for papers by Mattias K. Andersson Breakdown of academic impact, for papers by Silvio Roncella Breakdown of academic impact, for papers by Yoshinori Suminami Breakdown of academic impact, for papers by David C. Weksberg Breakdown of academic impact, for papers by Susan E. Lyons Breakdown of academic impact, for papers by Sébastien Albert Breakdown of academic impact, for papers by Hélène Salmon Breakdown of academic impact, for papers by Daoud Sie
Rankless by CCL
2026